1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: August 31, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site and communication
4. Time and method of issuing notice of board meeting: August 20, 2021 by mail
5. Moderator of the meeting: Chairman Wang Xueliang
6. Conference attendees (if any): Zhang Wei, secretary of the board of directors
7. Explanation of the legality, compliance and constitutionality of the convening:
The convening and convening procedures of this meeting, the qualifications of attending the meeting and the qualifications of the convener, and the voting procedures of the meeting are in compliance with the "Company Law of the People's Republic of China", "Articles of Association" and relevant laws, regulations and regulations, and the resolutions made are legal and valid.

(2) Meeting attendance
7 directors should be present at the meeting, and 7 directors should be present and authorized to attend.

2. Review of the proposal
(1) The proposal of "Regarding the Company's Proposal to Dissolve the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd."
1. The content of the proposal:
Based on the company's development needs, the company plans to terminate the continuous supervision agreement after full communication and friendly negotiation with Guotai Junan Securities Co., Ltd. and reach an agreement on termination related matters. Guotai Junan Securities Co., Ltd. will no longer serve as the company's continuous supervision of the main brokerage firm after this change has been approved by the National SME Share Transfer System.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(2) The proposal of "Explanatory Report on Releasing the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd." was considered and passed
1. The content of the proposal:
In accordance with relevant regulations such as the "Guidelines for the Consultation of the Leading Securities Dealers and Listed Companies in the National SME Share Transfer System to Resolve the Continuous Supervision Agreement" The transfer system submitted the "Explanatory Report on the Termination of the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd.".
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(3) The proposal of "Regarding the Company's Proposal to Sign a Continuous Supervision Agreement with Tianfeng Securities Co., Ltd." was considered and passed
1. The content of the proposal:
Based on the company's development needs, and in accordance with the relevant requirements and regulations of the China Securities Regulatory Commission and the National SME Share Transfer System, the company plans to sign the "Continuing Supervision Agreement" with Tianfeng Securities Co., Ltd. After this continuous supervision of the change of the main brokerage firm is reviewed and approved by the National SME Share Transfer System, Tianfeng Securities Co., Ltd. will take over the main brokerage firm and perform its continuous supervision obligations.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(4) The proposal of "Authorizing the Board of Directors to Fully Manage Matters Concerning the Continuous Supervision of the Change of the Leading Securities Dealer"
1. The content of the proposal:
In order to ensure the company's successful completion of this continuous supervision of the host brokerage change, it is proposed to authorize the company's board of directors to be fully responsible for the company's continuous supervision of the host brokerage change. The specific scope of authorization includes the declaration of relevant documents and information to the National SME Share Transfer System Company for the continuous supervision of the host brokerage change, approval and signing of the documents and contracts related to the continuous supervision of the host brokerage change, and the handling of the continuous supervision of the host brokerage company. All other matters related to the change.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(5) To consider and approve the "Recommendation for the Convening of the Second Extraordinary General Meeting of Shareholders of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd. in 2021"
1. The content of the proposal:
The report has been disclosed in the "Notice on Convening the Second Extraordinary General Meeting of Shareholders of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd. in 2021" published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn) Number: 2021-031)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
3. List of available documents
Resolutions of the 17th meeting of the second board of directors of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd.

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
August 31, 2021